Royalty Pharma plc Class A (RPRX) Stock | Share Price | News
RPRX · Health Care ·
United States
Royalty Pharma plc Class A (RPRX) is a company in the Health Care sector, based in United States. The stock is held in 20 ETFs we track – with its largest weight of 0.40 % in XUHC (msci-usa-health-care). That means you can hold Royalty Pharma indirectly and diversified through an ETF savings plan.
Above-average ETF coverage: 20 of the 95 ETFs we cover hold Royalty Pharma, spread across 10 indices. That puts the stock in more ETFs than 84.5 % of the 4,362 stocks we cover.
Price chart
Performance
| Year to date | +59.0 % | 1 year | +71.8 % |
|---|---|---|---|
| 1 month | +5.2 % | 3 months | +14.5 % |
| Calendar year 2025 | +51.5 % | ||
| Calendar year 2026 | +59.9 % |
Risk metrics
Correlated with
The strongest co-movers on top, the most inverse below. Low or negative values improve portfolio diversification.
| Instrument | r | −1 … +1 |
|---|---|---|
| Amgen Inc. | +0.58 | |
| AbbVie Inc. | +0.55 | |
| Bristol-Myers Squibb Company | +0.54 | |
| Vertex Pharmaceuticals Incorporated | +0.54 | |
| Gilead Sciences Inc. | +0.49 | |
| Biogen Inc. | +0.48 | |
| Qnity Electronics Inc. | -0.29 | |
| Microchip Technology Incorporated | -0.28 | |
| OPEN | -0.24 |
Key financials
Latest reported fiscal year (FY2025, period end 2025-12-31) as filed with the SEC.
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| FY2023 | 2.4 | 1.1 | 48.2 % |
| FY2024 | 2.3 | 0.9 | 37.9 % |
| FY2025 | 2.4 | 0.8 | 32.4 % |
Figures in USD bn. Source: SEC EDGAR (XBRL annual filings, public domain). US-listed SEC filers only.
Held in these ETFs
| ETF | Index | Weight |
|---|---|---|
| XUHC | msci-usa-health-care | 0.40 % |
| XUHL | msci-usa-health-care | 0.40 % |
| SPFS | msci-world-health-care | 0.30 % |
| XDWH | msci-world-health-care | 0.29 % |
| XDEV | msci-world-value | 0.15 % |
| XDEM | msci-world-momentum | 0.12 % |
| 2B7K | msci-world-sri | 0.11 % |
| WVAL | msci-world-value | 0.09 % |
| SPPW | msci-world | 0.04 % |
| XD9U | msci-usa | 0.04 % |
| XD9D | msci-usa | 0.04 % |
| SWWD | msci-world | 0.04 % |
| EUNL | msci-world | 0.03 % |
| XDWD | msci-world | 0.03 % |
| SPYY | msci-acwi | 0.03 % |
| XDWL | msci-world | 0.03 % |
| IUSQ | msci-acwi | 0.02 % |
| WIMI | msci-world-imi | 0.02 % |
| SPYI | msci-acwi-imi | 0.01 % |
| SPSA | msci-acwi-imi | 0.01 % |
Want to know how much Royalty Pharma plc Class A overlaps with the rest of your portfolio? Use the Portfolio X-Ray or the ETF overlap check.
Stocks with similar ETF exposure
Names that reach a portfolio through largely the same funds as Royalty Pharma — the figure counts the ETFs holding both.
Biogen Inc.BIIB · 20 shared ETFs · r +0.48
Revolution Medicines Inc.RVMD · 17 shared ETFs- Centene CorporationCNC · 19 shared ETFs
- Cooper Companies Inc.COO · 19 shared ETFs
Zimmer Biomet Holdings Inc.ZBH · 19 shared ETFs
United Therapeutics CorporationUTHR · 18 shared ETFs
Illumina Inc.ILMN · 16 shared ETFs
Insmed IncorporatedINSM · 16 shared ETFs
Latest Investment Intelligence News: Stocks
· MixedPOL tumbles 9.4% – August 26, 2026
· MixedSTX climbs 12.6% – August 25, 2026
· Risk-offSelling pressure hits markets, with only 30% of assets higher – August 24, 2026
· MixedCrypto, commodities & FX this week: Sui -9.0% · August 17–21, 2026
· MixedThe week in markets: MSCI Emerging Markets sets the tone for the week (+1.6%) · August 17–21, 2026